問題 › 利益を生む商品が分からない › 小売業
どの小売業者も、四壁費用をカバーしていると皆が思い込んでいる店舗を抱えていますが、実際にはそれらの店舗が補助を受けていることが多いです。 小売業者は特有の制約を抱えています。22件のリースが24カ月以内に満了しますが、どの店舗が実際に利益を生んでいるかを誰も示せません。それが明らかになるまで、四壁マージンは原因不明のまま動き続け、商品ラインごとの貢献度をめぐる議論は意見の域を出ません。
どの小売業者も、四壁費用をカバーしていると皆が思い込んでいる店舗を抱えていますが、実際にはそれらの店舗が補助を受けていることが多いです。 小売業者は特有の制約を抱えています。22件のリースが24カ月以内に満了しますが、どの店舗が実際に利益を生んでいるかを誰も示せません。それが明らかになるまで、四壁マージンは原因不明のまま動き続け、商品ラインごとの貢献度をめぐる議論は意見の域を出ません。
店舗別の貢献度を把握するのは本質的に難しいです。占有費や支援費の多くが共有されており、売上比例で配賦すると高売上店舗が高コストに見え、低売上店舗が効率的に見えるという逆転現象が起きるからです。これは低売上店舗が実際には disproportionate な注意や高い占有費率を要している場合に特に問題です。
実務的な方法は、四壁に真に traceable な費用だけを配賦し、残りは未配賦のままにしておくことです。これにより店舗別の貢献度と一つの正直な共有費用プールが得られ、誰も信用しない完全吸収原価計算よりはるかに有用です。
結果は通常、不快なものです。ほとんどのポートフォリオでは少数店舗が全体を支えており、長年営業している店舗の少なくとも一つが、誰もがそう思っていたのとは逆に長年赤字を続けています。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 四壁マージンが会社全体の数字としてのみ提示される
✓ リース更新が迫っているにもかかわらず店舗閉鎖が行われていない
✓ 同一店舗の貢献度について二人で異なる回答をする
通常、事態を悪化させる対応です。 占有費と支援費を各店舗に完全に吸収させ、恣意的なルールで作られた正確そうな数字を厳密に見えるからと擁護することです。
It is for you if you run or finance a retailer and product profitability is quoted as a company-wide gross margin. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 小売業者. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Marlin & Crowe, a sample company profile used for testing rather than a customer — $95M revenue, 40 stores.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Convert 21 high-productivity stores into a locked-in structural advantage by renegotiating leases at 3-5% rent reduction while preserving ship-from-store density.
The leak it closes. Occupancy cost leakage capped at 3-5% reduction; prevents 180-220 bps margin transfer to landlords
The assumption it rests on. Landlords accept 3-5% rent reduction rather than risk flagship vacancy — the engine put the probability at 0.75.
| Investment required | $0.15-0.25M legal, brokerage, and modeling fees |
| Expected return | 6.8× on $0.2M midpoint investment via $1.4-2.7M annual EBITDA uplift |
| Revenue, year 1 | $0 incremental revenue; $1.4-2.7M EBITDA protection |
| Revenue, year 2 | Same EBITDA protection plus option value of 8-year lease lock-in |
| Revenue, year 3 | Potential wholesale channel revenue enabled by secured real estate |
| Exit criteria | Terminate move if fewer than 14 landlords accept terms by Month 9 OR if traffic density <120 visitors/sq ft/day for two consecutive quarters; pivot to managed closure of lowest-productivity flagships |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Matrix Strategy, one of 29 engagements the platform runs. For 小売業者 it works through four-wall margin, sales per square foot, occupancy cost ratio and traffic density, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
今回の判断ではほとんど不要です。追跡可能な費用と未配賦プールで順位付けができ、行動の基になるのは順位です。完全なABCは、きっかけとなった判断より長く続くプロジェクトになりがちです。
明示的に述べ、支援の対価を価格に織り込んでください。本当に利益ある売上を引き寄せている赤字ラインは、名前のあるマーケティング費用です。誰かが意図して決めたものであれば問題ありません。
年1回と、商品構成に大きな変更があった後に行ってください。順位は数値より安定しているため、作業は回を重ねるごとに安価になります。
Materially, yes. 22 leases expire within 24 months and nobody can say which stores are actually profitable — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are four-wall margin, sales per square foot, occupancy cost ratio, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on four-wall margin and sales per square foot. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית